Previous close | 110.18 |
Open | 111.59 |
Bid | 112.81 x 200 |
Ask | 113.88 x 100 |
Day's range | 109.49 - 114.05 |
52-week range | 82.86 - 170.84 |
Volume | |
Avg. volume | 42,798 |
Market cap | 611.523M |
Beta (5Y monthly) | 0.82 |
PE ratio (TTM) | 666.88 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.64 (0.58%) |
Ex-dividend date | 31 May 2024 |
1y target est | N/A |
Lakewood, Colo., April 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the closing of its Amended and Restated Credit Agreement (the “Credit Agreement”), which provides up to $200 million of senior secured debt through a syndicate of banks led by JPMORGAN CHASE BANK, N.A. The Credit Agreement includes a $75 million senior secured term loan facility (the “Term Loan”) and a $125 million senior secured revolving credit facili
LAKEWOOD, Colo., April 04, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 14, 2024, to shareholders of record at the close of business on May 31, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life sciences tools and critical quality contro
LAKEWOOD, Colo., April 01, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device ind